Nature Communications (Oct 2020)
Author Correction: Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
- Wayne Vuong,
- Muhammad Bashir Khan,
- Conrad Fischer,
- Elena Arutyunova,
- Tess Lamer,
- Justin Shields,
- Holly A. Saffran,
- Ryan T. McKay,
- Marco J. van Belkum,
- Michael A. Joyce,
- Howard S. Young,
- D. Lorne Tyrrell,
- John C. Vederas,
- M. Joanne Lemieux
Affiliations
- Wayne Vuong
- Department of Chemistry, University of Alberta
- Muhammad Bashir Khan
- Department of Biochemistry, Membrane Protein Disease Research Group, University of Alberta
- Conrad Fischer
- Department of Chemistry, University of Alberta
- Elena Arutyunova
- Department of Biochemistry, Membrane Protein Disease Research Group, University of Alberta
- Tess Lamer
- Department of Chemistry, University of Alberta
- Justin Shields
- Department of Medical Microbiology and Immunology, University of Alberta
- Holly A. Saffran
- Department of Medical Microbiology and Immunology, University of Alberta
- Ryan T. McKay
- Department of Chemistry, University of Alberta
- Marco J. van Belkum
- Department of Chemistry, University of Alberta
- Michael A. Joyce
- Department of Medical Microbiology and Immunology, University of Alberta
- Howard S. Young
- Department of Biochemistry, Membrane Protein Disease Research Group, University of Alberta
- D. Lorne Tyrrell
- Department of Medical Microbiology and Immunology, University of Alberta
- John C. Vederas
- Department of Chemistry, University of Alberta
- M. Joanne Lemieux
- Department of Biochemistry, Membrane Protein Disease Research Group, University of Alberta
- DOI
- https://doi.org/10.1038/s41467-020-19339-y
- Journal volume & issue
-
Vol. 11,
no. 1
pp. 1 – 1
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.